Back to SO Squarepoint Ops LLC

PTGXPTGX

Showing 2 of 19 quarters

Position history for SOSquarepoint Ops LLC's holdings in PROTAGONIST THERAPEUTICS INC

No. Squarepoint Ops exited its PTGX (Protagonist Therapeutics) position in Q4 2024. Its Q3 2024 13F listed 18,566 shares worth $835,470. Squarepoint Ops already held PTGX in its Q4 2018 13F, the earliest on record, and held it in 15 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$835,470

Total Shares Change

-18,566

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$38.60
0
2024-Q3
Increased
18,566
+89.0%
$835,4700.0%$45.00
39

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used